نتایج جستجو برای: co amoxiclav

تعداد نتایج: 333054  

2013
Casper D. J. den Heijer John Penders Gé A. Donker Cathrien A. Bruggeman Ellen E. Stobberingh

Few studies have been performed on urinary tract infections (UTIs) in men. In the present study, general practitioners (n = 42) from the Dutch Sentinel General Practice Network collected urinary samples from 560 male patients (≥ 18 years) suspected of UTI and recorded prescribed antibiotic treatment. In this way, the antibiotic susceptibility of Gram-negative uropathogens, including extended-sp...

Journal: :The Journal of antimicrobial chemotherapy 2003
Michael R Jacobs David Felmingham Peter C Appelbaum Reuben N Grüneberg

OBJECTIVES The Alexander Project is a continuing surveillance study, begun in 1992, examining the susceptibility of pathogens involved in adult community-acquired respiratory tract infections (CARTI) to a range of antimicrobial agents. MATERIALS AND METHODS This study tested the susceptibility of isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected ...

Journal: :Egyptian Journal of Chemistry 2021

Augmentin is a chemical mixture component medicine (co medicine) known as co-amoxiclav and it famous antibiotic used for treatment of number bacterial infections, so dangerous to be left in the environment after its expired harmful child’s, present work introduces an idea using form potential non-toxic (green ) corrosion inhibitor steel 1.0 N HCl. Five analytical techniques were evaluate inhibi...

Journal: :The Journal of antimicrobial chemotherapy 2003
Eric L Nuermberger William R Bishai

Sir, We wish to comment on the paper by Van Kerkhoven et al.,1 to dispel certain misconceptions that may arise from a cursory review of their study. The authors present a 3 year retrospective chart review of patients hospitalized with pneumococcal bacteraemia at a single hospital. Of the 136 patients identified, 14 (10.3%) and 33 (24.3%) had isolates non-susceptible to penicillin and erythromyc...

Journal: :Journal of Medical Case Reports 2007
Adriana Orzechowska Sandra Lacey Geraldine Soosay Mark Melzer

We report a case of a 49-year-old male with a history of chronic alcoholism and evidence of a pancreatic pseudocyst on CT scanning. He presented with a 3-days history of fever, loss of appetite and upper abdominal pain. Blood cultures grew Klebsiella pneumoniae and he improved clinically with a seven-day course of intravenous co-amoxiclav and metronidazole. Two weeks later he was readmitted to ...

Journal: :Antimicrobial agents and chemotherapy 1993
P H McWhinney S Patel R A Whiley J M Hardie S H Gillespie C C Kibbler

All 47 sequential blood culture isolates of viridans group streptococci obtained from febrile neutropenic patients receiving quinolone prophylaxis were susceptible to vancomycin, teicoplanin, and imipenem. Resistance to benzylpenicillin (MIC for 50% of isolates [MIC50], 0.125 microgram/ml) and ceftazidime (MIC50, 4 micrograms/ml) was common. Most isolates were susceptible to amoxicillin, co-amo...

Journal: :Antimicrobial agents and chemotherapy 2002
R Finch D Schürmann O Collins R Kubin J McGivern H Bobbaers J L Izquierdo P Nikolaides F Ogundare R Raz P Zuck G Hoeffken

The objective of the present trial was to compare the efficacy, safety, and tolerability of moxifloxacin (400 mg) given intravenously (i.v.) once daily followed by oral moxifloxacin (400 mg) for 7 to 14 days with the efficacy, safety, and tolerability of co-amoxiclav (1.2 g) administered by i.v. infusion three times a day followed by oral co-amoxiclav (625 mg) three times a day, with or without...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید